Gene Query: RALBP1

Dataset Description Geneva Score
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 42.89
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 39.16
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 32.23
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 27.1
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 26.66
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 26.02
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 25.3
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 24.53
SNHG5 siRNA knock down in HCT116 cells 24.16
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 22.23
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 21.12
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 20.99
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 20.75
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 20.72
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 20.49
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 19.75
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 19.34
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 19.34
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 19.22
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 19.2
Differetially expressed genes after hTR overexpression in U2OS cells 19.02
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 18.33
The regulartory role of ZCCHC24 in splicing machinery 17.86
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 17.46
Genome-wide analysis of the Integrator complex 17.2
Genome-wide analysis of the Integrator complex (HTS) 17.2
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 16.96
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 16.87
Chromatin-informed inference of transcriptional programs in gynecologic cancers 16.87
Peptidomimetic blockade of MYB in acute myeloid leukemia 16.47
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 16.47
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 15.99
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 15.99
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 15.59
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 15.06
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 14.37
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 14.37
Intron retention induced by microsatellite expansions as a disease biomarker. 14.27
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 13.76
RNA-seq of YB5 cells treated with Proscillaridin A 13.7
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 13.46
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 13.28
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.75
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 12.53
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 12.38
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 12.38
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 12.36
MYC dependent mRNA translation shapes gene expression and cell biology 12.3
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 12.28
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 12.28
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 12.24
hTERT promotes cell adhesion and migration independent of telomerase activity 12.23
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 11.88
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 11.88
Human neutrophil genome during PMA- and E. coli encounter-induced activation 11.58
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 11.58
METTL3 promotes translation in human cancer cells 11.4
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 11.27
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 11.13
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 11.13
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 11.09
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.03
RNA-Seq in neutrophils from Antiphospholipid Syndrome 11.02
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 10.95
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 10.88
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 10.87
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 10.82
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 10.76
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 10.75
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 10.75
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.72
Global analysis of enhancer targets: Mosaic-seq 10.67
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 10.55
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 10.38
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 10.37
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 10.37
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 10.21
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.2
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.08
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 10.04
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 10.04
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 10.02
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 9.99
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 9.81
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.67
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.6
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 9.56
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 9.54
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 9.52
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 9.52
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 9.45
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 9.45
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 9.43
Differential expression of genes in AD169-infected MRC5. 9.4
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.39
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 9.38
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 9.38
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 9.37
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.3
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 9.21
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.14
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 9.14
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 9.13
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.05
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.01
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 8.97
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 8.93
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.89
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 8.87
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 8.74
RNA sequencing of primary human platelets and in vitro cell lines 8.74
Role of CD133 molecule in WNT response and renal repair 8.73
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 8.71
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 8.63
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 8.61
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.61
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 8.6
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 8.58
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.46
Identification of global regulators of T-helper cell lineage specification 8.46
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 8.41
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 8.41
TCF7L1 knockdown in pancreatic cancer 8.31
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 8.3
Ebola virus (EBOV) infection of ARPE-19 cells 8.24
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 8.21
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 8.2
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.16
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 8.16
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 8.14
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 8.12
The evolution of N6-methyladenosine in primates 8.12
Disruption of the exocyst induces podocyte loss and dysfunction 8.12
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 8.07
CROP-Seq in Primary Human T Cells 8.07
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.05
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.91
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 7.91
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 7.91
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.82
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 7.82
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 7.82
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 7.77
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 7.74
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 7.74
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 7.66
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 7.65
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 7.58
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 7.58
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.56
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.53
EWSR1 influences alternative splicing through direct and indirect mechanisms 7.52
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 7.43
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 7.43
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 7.37
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 7.36
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 7.36
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 7.36
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.35
Transcriptome analysis of Zika infected neural stem cells 7.34
Zika infected neural stem cells 7.34
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.34
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 7.27
Integrin signaling regulates YAP/TAZ to control skin homeostasis 7.25
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.25
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 7.25
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 7.25
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 7.17
RNA-seq analysis to identify the genes regulated by p53-SET interplay 7.14
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.12
Exploring the RNA landscape of endothelial exosomes 7.12
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.05
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.04
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 7.0
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 6.99
G-quadruplex structures mark human regulatory chromatin 6.92
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 6.86
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 6.85
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 6.84
ARID1A regulates condensin II distribution and chromosomal partition 6.84
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 6.83
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 6.82
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 6.82
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.8
Inhibition of TNBC metastasis by Gpx1 6.79
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 6.75
High-throughput sequencing of pluripotent cells 6.73
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.7
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.7
RNA-seq of naive and primed ES cells 6.69
RNA-seq analysis of the human fetal kidney. 6.66
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 6.64
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 6.64
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.64
Survival of pancreatic cancer cells lacking KRAS function 6.62
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 6.55
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 6.51
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 6.49
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.49
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.49
ETV7 and interferon response 6.49
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.43
Novel Targeting of Transcription and Metabolism in Glioblastoma 6.42
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.39
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.38
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 6.38
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 6.38
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.31
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.31
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.29
Landscape and variation of RNA secondary structure across the human transcriptome 6.28
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 6.27
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 6.27
ARS2 is a general suppressor of pervasive transcription [RNAseq] 6.27
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 6.27
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.22
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.22
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.2
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 6.18
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 6.12
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.11
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 6.11
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.09
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 6.09
Transcriptomic analysis of the HOTAIR-regulated genes 6.08
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 6.08
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 6.03
RNA m5C Methylation in breast cancer using MeRIP-Seq 6.02
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 6.0
Effect of BMP inhibition or stimulation of primary human keratinocytes 6.0
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.95
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.92
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 5.89
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.89
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 5.89
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 5.66
Metastasis in triple-negative breast cancer 5.66
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 5.61
Molecular Criteria for Defining the Naive Human Pluripotent State 5.61
Oncogenic roles of ARID5B in T-ALL 5.55
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 5.55
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 5.5
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 5.5
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.49
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 5.4
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.39
mRNA-Seq profiling of human developing kidney 5.3
Identification of global XBP1s target gene expression in human prostate cancer cells 5.26
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.26
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.26
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 5.18
Gene expression profile of human placenta from T. Cruzi infected mothers 5.17
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.12
Gene expression in GBM with Cav3.2 inhibition 5.08
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.05
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 5.04
LncRNA expression profiling of ischemic stroke patients 4.99
Genome-wide mapping of TEL-AML1 targets in acute leukemia 4.97
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.85
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 4.83
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 4.82
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.74
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.74
Widespread intronic polyadenylation diversifies immune cell transcriptomes 4.74
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.73
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.73
RNA-sequencing 4.7
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.69
TFAP2C signalling in human fibroblasts 4.64
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.63
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 4.62
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 4.62
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.59
Gene expression profile in breast cancer cells 4.56
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.56
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.53
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.52
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 4.51
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 4.51
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 4.51
Dysregulated immune system networks in war veterans with PTSD 4.49
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 4.47
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 4.45
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 4.45
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 4.43
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.35
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 4.35
Human Treg NaCl stimulation 4.35
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.22
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 4.21
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.06
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.05
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.01
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.99
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.97
Changes in human endometrial gland transcriptome over the window of implantation 3.95
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 3.94
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.91
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.87
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.83
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.83
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 3.83
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 3.83
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.82
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.82
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.82
Loss of CREBBP results in gene expression repression in lymphoma cells 3.82
Molecular Mechanisms of Endothelial Hyperpermeability 3.81
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.81
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.81
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.78
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 3.77
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.73
Transcriptome of diurnal human blood neutrophils 3.72
Age-Related Gene Expression Changes in Prostate Cancer Patients 3.67
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 3.67
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.66
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.66
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.62
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.56
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.49
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.47
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.45
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 3.45
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.42
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.42
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.39
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 3.39
Universal alternative splicing of noncoding exons 3.38
CDK12 mediated transcriptional regulation in U2OS cells 3.36
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.3
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.3
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.26
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.26
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 3.19
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 3.19
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.17
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 3.12
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 3.1
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 3.1
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.1
miR-93 Targets in Human Endothelial Cells 3.09
Trascriptome of thyroid cancer-induced macrophages 3.08
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 3.08
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.07
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.07
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.07
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.07
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 3.04
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.98
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.96
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 2.93
scRNASeq analysis of cycling cardiomyocytes 2.89
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.85
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.85
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.71
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.68
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.67
Targeting MTHFD2 in Acute Myeloid Leukemia 2.66
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.62
Copper Regulation of HIF-1 Transcription Activity 2.61
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.61
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.59
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 2.58
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.53
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 2.52
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.5
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.5
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.5
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.48
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.47
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.46
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.46
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.45
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.35
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.35
Aging-associated patterns in the expression of human endogenous retroviruses 2.33
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.31
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.3
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 2.28
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 2.28
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 2.27
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.27
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.25
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.22
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.19
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.12
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.09
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.04
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.01
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.99
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.97
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.93
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.89
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.86
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.85
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.83
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 1.83
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.82
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.81
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.78
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.77
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.77
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.74
Identification of differentially expressed genes between senescence and senescence bypass cells 1.7
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.61
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.58
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.58
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 1.5
p63 controls the enhancer landscape during keratinocyte differentiation 1.49
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.48
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.47
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.46
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.46
Enhancer activation during EGF response 1.45
Human Treg IL-12 stimulation 1.36
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.33
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.29
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.27
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.25
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.25
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.23
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 1.23
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.23
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.17
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.17
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.16
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.16
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.16
Global transcriptome analysis of WT versus HEB-/- hESCs 1.15
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 1.14
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.14
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.08
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.07
Modeling Human Cancer-induced Cachexia (Human) 1.03
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.03
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 1.02
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.99
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.98
ML29755 RNA-seq data 0.98
MicroRNA targetome analysis during HCMV infection 0.92
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.9
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.88
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.88
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.84
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.8
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.8
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.78
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.75
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.75
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.74
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.7
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.7
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.69
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 0.69
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.67
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.64
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.63
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.63
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.58
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.57
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.5
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.48
Expression analysis of the TAF1 syndrome 0.47
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.42
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.42
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.41
Modulation of nonsense-mediated decay by rapamycin 0.39
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.38
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.3
NHLRC1 re-expression in cancer cells 0.29
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.26
Specific molecular signatures underlie response to decitabine in CMML 0.26
Deep RNA sequencing of the human placental transcriptome 0.25
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.24
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.24
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.24
The pioneer factor CEBPA modulates vitamin D signaling 0.24
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 0.22
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.2
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.2
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.2
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.18
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.17
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.17
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.16
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.14
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.07
Determining mRNA half-lives on a transcriptome-wide scale 0.04
Myc activation coordinates gene transcription and protein translation responses 0.04
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.02
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.02
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.02
Preclinical model of obesity and ER-positive breast cancer 0.02
RNA-seq of primary patient AML samples 0.02
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.01
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.01
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.0
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation